logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Angina Pectoris Variant

    FiltersReset Filters
    14 results

    • amlodipine besylate

      (AMLODIPINE BESYLATE)
      Cipla USA Inc.
      Usage: Amlodipine besylate is indicated for treating hypertension to reduce the risk of cardiovascular events and for managing chronic stable angina, vasospastic angina, and angiographically documented coronary artery disease (CAD) to minimize hospitalization and the need for coronary revascularization.

    • amlodipine besylate

      (AMLODIPINE BESYLATE)
      Epic Pharma, LLC
      Usage: Amlodipine Besylate Tablets are indicated for treating hypertension, chronic stable angina, vasospastic angina, and to reduce hospitalization risk in patients with documented coronary artery disease. It can be used alone or with other antihypertensive or antianginal agents to manage cardiovascular risk.

    • caduet

      (amlodipine besylate and atorvastatin calcium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: CADUET (amlodipine and atorvastatin) is indicated for patients requiring both hypertension management and lipid control. Amlodipine treats high blood pressure and various types of angina, while atorvastatin reduces risk of cardiovascular events and lowers LDL cholesterol in hyperlipidemia.

    • katerzia

      (Amlodipine)
      Azurity Pharmaceuticals, Inc.
      Usage: KATERZIA is indicated for treating hypertension in adults and children (6+ years) to lower blood pressure, thus reducing cardiovascular event risks. It is also used for symptomatic treatment of chronic stable angina, vasospastic angina, and to decrease hospitalization and revascularization risk in patients with documented coronary artery disease.

    • nifedipine

      (Nifedipine)
      Chartwell RX, LLC
      Usage: Nifedipine is indicated for managing vasospastic angina and chronic stable angina. It addresses vasospastic angina confirmed by specific criteria and is used in chronic stable angina when patients remain symptomatic despite adequate beta-blocker or nitrate therapy. Care is needed when combined with beta-blockers due to hypotension risks.

    • nifedipine

      (nifedipine)
      Ingenus Pharmaceuticals, LLC
      Usage: Nifedipine extended-release tablets are indicated for the management of vasospastic angina, chronic stable angina, and hypertension. It helps reduce angina frequency, increase exercise tolerance, and lower blood pressure, thereby decreasing the risk of cardiovascular events such as strokes and myocardial infarctions.

    • nifedipine

      (Nifedipine)
      TWI Pharmaceuticals, Inc.
      Usage: Nifedipine extended-release tablets are indicated for the management of vasospastic angina, chronic stable angina, and hypertension. They help alleviate angina symptoms and lower blood pressure, reducing cardiovascular event risks like strokes and myocardial infarctions in patients experiencing inadequate control with other treatments or those who cannot tolerate them.

    • nifedipine

      (nifedipine)
      Elite Pharmaceutical Solution, Inc.
      Usage: Nifedipine Extended-Release Tablets are indicated for the management of vasospastic angina, chronic stable angina, and hypertension. They help relieve angina symptoms, improve exercise tolerance, and lower blood pressure, reducing cardiovascular event risks. Concurrent use with other antihypertensive agents is possible but requires careful monitoring.

    • nifedipine

      (Nifedipine)
      TWi Pharmaceuticals, Inc.
      Usage: Nifedipine extended-release tablets are indicated for managing vasospastic angina, chronic stable angina, and hypertension. They help alleviate angina symptoms and lower blood pressure, reducing the risk of cardiovascular events. Use may involve combination therapy for optimal blood pressure control and symptom management.

    • nifedipine

      (Nifedipine)
      Chartwell RX, LLC
      Usage: Nifedipine Extended-release Tablet is indicated for managing vasospastic angina, chronic stable angina, and hypertension. It helps alleviate angina symptoms, increases exercise tolerance, and reduces blood pressure, thereby lowering the risk of cardiovascular events like strokes and myocardial infarctions. It can be used alone or with other antihypertensive agents.